Updated: Dec 1, 2025

Quantitative Autonomic Testing
Published on: July 19, 2011
Scott Dryden-Peterson1, Gustavo E Velásquez1, Thomas J Stopka1
1Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts (Dryden-Peterson, Velásquez, Lockman, Ojikutu); Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health (Dryden-Peterson, Lockman), Botswana Harvard AIDS Institute (Dryden-Peterson, Lockman), Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts (Velásquez, Ojikutu); Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts (Velásquez); Department of Public Health and Community Medicine, Tufts University School of Medicine (Stopka); Tufts Clinical and Translational Science Institute (Stopka); Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts (Davey).
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
COVID-19 testing in Massachusetts showed increasing misalignment with epidemic intensity. Vulnerable communities faced greater testing gaps, risking intensified outbreaks.
Area of Science:
Background:
Conclusions: